Equity Overview
Price & Market Data
Price: $5.45
Daily Change: -$0.08 / 1.47%
Daily Range: $5.33 - $5.51
Market Cap: $65,921,188
Daily Volume: 28,661
Performance Metrics
1 Week: -9.38%
1 Month: -53.72%
3 Months: -53.08%
6 Months: -55.14%
1 Year: -60.31%
YTD: -53.48%
Company Details
Employees: 150
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.